clearance under section 510(k) of the Federal Food, Drug, and Cosmetic Act, is in effect, and— (1) (A) for which, with respect to a drug included in the list described in section 505(j)(7) of the Federal Food, Drug, and Cosmetic Act, each patent included with respect to such drug in such list has expired, or each patent that claims a biological product has expired